Standard InChI: InChI=1S/C22H15ClF3N3O3/c23-17-3-1-2-16(22(24,25)26)18(17)19-15(20(32-29-19)13-8-9-27-10-13)11-28-14-6-4-12(5-7-14)21(30)31/h1-10,27-28H,11H2,(H,30,31)
1.Meijer FA, Doveston RG, de Vries RMJM, Vos GM, Vos AAA, Leysen S, Scheepstra M, Ottmann C, Milroy LG, Brunsveld L.. (2020) Ligand-Based Design of Allosteric Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Inverse Agonists., 63 (1):[PMID:31821760][10.1021/acs.jmedchem.9b01372]
2.Meijer FA,van den Oetelaar MCM,Doveston RG,Sampers ENR,Brunsveld L. (2021) Covalent Occlusion of the RORγt Ligand Binding Pocket Allows Unambiguous Targeting of an Allosteric Site., 12 (4.0):[PMID:33854703][10.1021/acsmedchemlett.1c00029]
3.Leijten-van de Gevel IA, van Herk KHN, de Vries RMJM, Ottenheym NJ, Ottmann C, Brunsveld L.. (2022) Indazole MRL-871 interacts with PPARγ via a binding mode that induces partial agonism., 68 [PMID:35714534][10.1016/j.bmc.2022.116877]
4.Meijer FA, Saris AOWM, Doveston RG, Oerlemans GJM, de Vries RMJM, Somsen BA, Unger A, Klebl B, Ottmann C, Cossar PJ, Brunsveld L.. (2021) Structure-Activity Relationship Studies of Trisubstituted Isoxazoles as Selective Allosteric Ligands for the Retinoic-Acid-Receptor-Related Orphan Receptor γt., 64 (13.0):[PMID:34008974][10.1021/acs.jmedchem.1c00475]